BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191025T080000
DTEND;TZID=America/New_York:20191025T130000
DTSTAMP:20191023T171430Z
CREATED:20191023T170519Z
LAST-MODIFIED:20191023T171430Z
UID:6957-1571990400-1572008400@scienceinboston.com
SUMMARY:College & Career Exploration Day - Register to Volunteer
DESCRIPTION:Cambridge\, MA is the “hub” of the life sciences industry and provides many opportunities for students in the area to engage in career exploration experiences. MassBioEd recognizes that these same opportunities are not accessible to students in Western\, MA. College & Career Exploration Day allows these students to gain exposure to diverse fields of study and career options in many sectors of the life sciences. \nThis program is a one day event where 40+ volunteers from the life sciences industry mentor high school students through rapid-paced mentoring sessions. Students learn first-hand from industry volunteers about their unique qualifications\, educational backgrounds\, and interests that brought them to biotechnology and the contribution each of their roles make in this evolving industry. \nA mentor should be prepared to: \n\nProvide a brief presentation on what they do in the field\, for what organization\, and how that organization aspires to positively impact lives\,\nDiscuss the life sciences in general and share their own experiences within the field\,\nReflect on their personal journey and how they got to where they are today\,\nAllow time for questions from students\,\nProvide a demonstration or activity.\n\nThe BioTeach team is willing to provide volunteers with any feedback or ideas torwards their presentation and how to engage the students. \nSample Event Schedule: \n\n8:00 am: Registration\n9:00 am: Introduction/ Welcome Note\n9:30 am: Mentor Sessions/ Campus Tours\n11:00 am: Mentor Sessions/ Campus Tours\n12:20 pm: Lunch\n1:00 pm: Evaluations and Dismissal\n\nFor questions\, please contact Kretsy Mondesir at kretsy.mondesir@massbio.org or 617-674-5134.
URL:https://scienceinboston.com/event/college-career-exploration-day-register-to-volunteer/
LOCATION:Campus Center Auditorium\, UMass Amherst\, 1 Campus Center Way\, Amherst\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191025T080000
DTEND;TZID=America/New_York:20191025T130000
DTSTAMP:20191023T170519Z
CREATED:20191023T170519Z
LAST-MODIFIED:20191023T170519Z
UID:27362-1571990400-1572008400@scienceinboston.com
SUMMARY:College & Career Exploration Day - Register to Volunteer
DESCRIPTION:Cambridge\, MA is the “hub” of the life sciences industry and provides many opportunities for students in the area to engage in career exploration experiences. MassBioEd recognizes that these same opportunities are not accessible to students in Western\, MA. College & Career Exploration Day allows these students to gain exposure to diverse fields of study and career options in many sectors of the life sciences. \nThis program is a one day event where 40+ volunteers from the life sciences industry mentor high school students through rapid-paced mentoring sessions. Students learn first-hand from industry volunteers about their unique qualifications\, educational backgrounds\, and interests that brought them to biotechnology and the contribution each of their roles make in this evolving industry. \nA mentor should be prepared to: \n\nProvide a brief presentation on what they do in the field\, for what organization\, and how that organization aspires to positively impact lives\,\nDiscuss the life sciences in general and share their own experiences within the field\,\nReflect on their personal journey and how they got to where they are today\,\nAllow time for questions from students\,\nProvide a demonstration or activity.\n\nThe BioTeach team is willing to provide volunteers with any feedback or ideas torwards their presentation and how to engage the students. \nSample Event Schedule: \n\n8:00 am: Registration\n9:00 am: Introduction/ Welcome Note\n9:30 am: Mentor Sessions/ Campus Tours\n11:00 am: Mentor Sessions/ Campus Tours\n12:20 pm: Lunch\n1:00 pm: Evaluations and Dismissal\n\nFor questions\, please contact Kretsy Mondesir at kretsy.mondesir@massbio.org or 617-674-5134.
URL:https://scienceinboston.com/event/college-career-exploration-day-register-to-volunteer-2/
LOCATION:Campus Center Auditorium\, UMass Amherst\, 1 Campus Center Way\, Amherst\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191024T160000
DTEND;TZID=America/New_York:20191024T170000
DTSTAMP:20191023T170138Z
CREATED:20191023T170138Z
LAST-MODIFIED:20191023T170138Z
UID:6954-1571932800-1571936400@scienceinboston.com
SUMMARY:The Future of CAR T Cell Therapy for Pediatric Leukemia
DESCRIPTION:Overview\n\nSPEAKER: Dr. Terry J. Fry\, M.D. \nSPEAKER BIO: Dr. Fry is a Professor of Pediatrics\, Hematology and Immunology\, Co-Director of the Human Immunology and Immunotherapy Initiative\, Director of Cancer Immunotherapy at the University of Colorado School of Medicine and holds the Robert and Kathleen Clark Endowed Chair in Pediatric Cancer Therapeutics at the Children’s Hospital Colorado.  He arrived at Children’s Hospital Colorado in 2018 after serving as Head of the Hematologic Malignancies Section in the Pediatric Oncology Branch at the NIH where he led efforts in Cellular Immunotherapy for pediatric leukemia.  Prior to the NIH\, Dr. Fry was Chief of Blood and Marrow Transplantation at Children’s National Medical Center in Washington\, DC.  Dr. Fry’s research focuses on the preclinical and clinical development of chimeric antigen receptor T cells for pediatric cancers.  He serves on the Committee for Scientific Affairs for the American Society of Hematology\, Vice Chair for Biology in the Cellular Therapy Committee of the Children’s Oncology Group and was recently elected into the American Society for Clinical Investigation. \nABSTRACT: Dr. Fry is an international expert in the development of cellular therapies for the management of children with cancer\, with an emphasis on acute leukemia.  He will present work from his laboratory that will inform translation of new cellular therapies into pediatric clinical trials.  He will also provide translational data that addresses the issue of duration of response and mechanism of resistance to cellular therapies. \nLIVE WEBCAST:  https://externalmediasite.partners.org/Mediasite/Play/a46012e230fe42229252e4275e05008d1d \nPARKING: Please park in the Yawkey Garage\, P3 or lower. Write “WS” on the back of your parking ticket and parking will be free upon your exit.
URL:https://scienceinboston.com/event/the-future-of-car-t-cell-therapy-for-pediatric-leukemia/
LOCATION:Dana Farber Cancer Institute\, 450 Brookline Avenue\, Yawkey Center for Cancer Care\, Lavine Family Dining Pavilion\, 3rd Floor\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191024T160000
DTEND;TZID=America/New_York:20191024T170000
DTSTAMP:20191023T170138Z
CREATED:20191023T170138Z
LAST-MODIFIED:20191023T170138Z
UID:27361-1571932800-1571936400@scienceinboston.com
SUMMARY:The Future of CAR T Cell Therapy for Pediatric Leukemia
DESCRIPTION:Overview\n\nSPEAKER: Dr. Terry J. Fry\, M.D. \nSPEAKER BIO: Dr. Fry is a Professor of Pediatrics\, Hematology and Immunology\, Co-Director of the Human Immunology and Immunotherapy Initiative\, Director of Cancer Immunotherapy at the University of Colorado School of Medicine and holds the Robert and Kathleen Clark Endowed Chair in Pediatric Cancer Therapeutics at the Children’s Hospital Colorado.  He arrived at Children’s Hospital Colorado in 2018 after serving as Head of the Hematologic Malignancies Section in the Pediatric Oncology Branch at the NIH where he led efforts in Cellular Immunotherapy for pediatric leukemia.  Prior to the NIH\, Dr. Fry was Chief of Blood and Marrow Transplantation at Children’s National Medical Center in Washington\, DC.  Dr. Fry’s research focuses on the preclinical and clinical development of chimeric antigen receptor T cells for pediatric cancers.  He serves on the Committee for Scientific Affairs for the American Society of Hematology\, Vice Chair for Biology in the Cellular Therapy Committee of the Children’s Oncology Group and was recently elected into the American Society for Clinical Investigation. \nABSTRACT: Dr. Fry is an international expert in the development of cellular therapies for the management of children with cancer\, with an emphasis on acute leukemia.  He will present work from his laboratory that will inform translation of new cellular therapies into pediatric clinical trials.  He will also provide translational data that addresses the issue of duration of response and mechanism of resistance to cellular therapies. \nLIVE WEBCAST:  https://externalmediasite.partners.org/Mediasite/Play/a46012e230fe42229252e4275e05008d1d \nPARKING: Please park in the Yawkey Garage\, P3 or lower. Write “WS” on the back of your parking ticket and parking will be free upon your exit.
URL:https://scienceinboston.com/event/the-future-of-car-t-cell-therapy-for-pediatric-leukemia-2/
LOCATION:Dana Farber Cancer Institute\, 450 Brookline Avenue\, Yawkey Center for Cancer Care\, Lavine Family Dining Pavilion\, 3rd Floor\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191024T083000
DTEND;TZID=America/New_York:20191024T120000
DTSTAMP:20191023T165052Z
CREATED:20191023T165052Z
LAST-MODIFIED:20191023T165052Z
UID:6952-1571905800-1571918400@scienceinboston.com
SUMMARY:MD Biosciences Symposium: Advances in Preclinical and Translational CNS Research
DESCRIPTION:Overview\n\nSymposium Overview \nSession I: Neurophysiology \n\n  Spinal cord injury in a dish\n  Synapse imaging: assessment of drug selection and efficacy\n  Histoneurology: IHC staining and analysis of neurological diseases\n  Patch clamp method for drug screening\n\n  \nSession II: Quantitative Output for Neurodegenerative Diseases Using in vivo Electrophysiology \n\nApplication of Electrophysiology as an endpoint in EAE Multiple Sclerosis studies\n\n  \nSession III: Pig Models of Pain \n\nPost-operative pain\nModified post-operative pain\nNeuropathic pain\n\n  \nMeet The Speakers \nSigal Meilin\, PhD\, Chief Scientific Officer \nDr. Meilin’s passion over 25 years has been in the understanding of neuro-degeneration and pain processes. Her research focus has been on exploring and creating true models of pain including translational models in pigs which closely mimic and forecast drug activity in humans. The MD Biosciences Innovalora laboratories\, under the scientific leadership of Sigal Meilin\, have become leaders in the discovery and validation of novel pathways and new candidate drugs. Sigal Meilin holds a PhD from Bar Ilan University in Tel Aviv\, Israel where she also continued her research involving multi-parametric monitoring of the living brain under oxygen stress and the cross talk between the immune system and the neuronal system in neurodegenerative disease. She was the leader of the pharmacology department of Pharmos\, Ltd\, prior to joining MD Biosciences in 2006. \nYoav Shulman\, PhD\, Neurophysiology Laboratory Manager \nDr. Shulman leads the neurophysiology and electrophysiology laboratories at MD Biosciences Innovalora. His primary focus is on method development and validation as well as execution of sponsor studies together with his team. Prior to joining MD Biosciences Innovalora\, Yoav completed his doctoral work at the Ben Gurion University of the Negev followed by a post-doctoral research at the Technion in Haifa\, Israel. Specialties include the establishment of spinal cord injury model using primary cultures from adult rat spine and peripheral nerve injury model using primary cultures from adult rat DRG. Other experiences include the establishment of an electrophysiology system for pharmacology assays using primary hippocampal cultures (Orenbuch et al. 2012)\, live Ca²ꜙ imaging and electrophysiology on ex-vivo brain slices (Sandler et al. 2016)\, live protein expression and movement\, identifying novel protein-protein interactions using a wide array of technologies (Shulman et al. 2015)\, Brain stem slices and electrophysiology measurements for ionic channel identification (Safori et al. 2015) and live EMPs\, SSEPs\, EEG and EMG for monitoring human brain and spine procedures in OR.
URL:https://scienceinboston.com/event/md-biosciences-symposium-advances-in-preclinical-and-translational-cns-research/
LOCATION:Royal Sonesta Boston\, 40 Edwin H Land Boulevard\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191024T083000
DTEND;TZID=America/New_York:20191024T120000
DTSTAMP:20191023T165052Z
CREATED:20191023T165052Z
LAST-MODIFIED:20191023T165052Z
UID:27360-1571905800-1571918400@scienceinboston.com
SUMMARY:MD Biosciences Symposium: Advances in Preclinical and Translational CNS Research
DESCRIPTION:Overview\n\nSymposium Overview \nSession I: Neurophysiology \n\n  Spinal cord injury in a dish\n  Synapse imaging: assessment of drug selection and efficacy\n  Histoneurology: IHC staining and analysis of neurological diseases\n  Patch clamp method for drug screening\n\n  \nSession II: Quantitative Output for Neurodegenerative Diseases Using in vivo Electrophysiology \n\nApplication of Electrophysiology as an endpoint in EAE Multiple Sclerosis studies\n\n  \nSession III: Pig Models of Pain \n\nPost-operative pain\nModified post-operative pain\nNeuropathic pain\n\n  \nMeet The Speakers \nSigal Meilin\, PhD\, Chief Scientific Officer \nDr. Meilin’s passion over 25 years has been in the understanding of neuro-degeneration and pain processes. Her research focus has been on exploring and creating true models of pain including translational models in pigs which closely mimic and forecast drug activity in humans. The MD Biosciences Innovalora laboratories\, under the scientific leadership of Sigal Meilin\, have become leaders in the discovery and validation of novel pathways and new candidate drugs. Sigal Meilin holds a PhD from Bar Ilan University in Tel Aviv\, Israel where she also continued her research involving multi-parametric monitoring of the living brain under oxygen stress and the cross talk between the immune system and the neuronal system in neurodegenerative disease. She was the leader of the pharmacology department of Pharmos\, Ltd\, prior to joining MD Biosciences in 2006. \nYoav Shulman\, PhD\, Neurophysiology Laboratory Manager \nDr. Shulman leads the neurophysiology and electrophysiology laboratories at MD Biosciences Innovalora. His primary focus is on method development and validation as well as execution of sponsor studies together with his team. Prior to joining MD Biosciences Innovalora\, Yoav completed his doctoral work at the Ben Gurion University of the Negev followed by a post-doctoral research at the Technion in Haifa\, Israel. Specialties include the establishment of spinal cord injury model using primary cultures from adult rat spine and peripheral nerve injury model using primary cultures from adult rat DRG. Other experiences include the establishment of an electrophysiology system for pharmacology assays using primary hippocampal cultures (Orenbuch et al. 2012)\, live Ca²ꜙ imaging and electrophysiology on ex-vivo brain slices (Sandler et al. 2016)\, live protein expression and movement\, identifying novel protein-protein interactions using a wide array of technologies (Shulman et al. 2015)\, Brain stem slices and electrophysiology measurements for ionic channel identification (Safori et al. 2015) and live EMPs\, SSEPs\, EEG and EMG for monitoring human brain and spine procedures in OR.
URL:https://scienceinboston.com/event/md-biosciences-symposium-advances-in-preclinical-and-translational-cns-research-2/
LOCATION:Royal Sonesta Boston\, 40 Edwin H Land Boulevard\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191024T083000
DTEND;TZID=America/New_York:20191024T120000
DTSTAMP:20190909T151923Z
CREATED:20190909T151923Z
LAST-MODIFIED:20190909T151923Z
UID:6457-1571905800-1571918400@scienceinboston.com
SUMMARY:Advances in Preclinical & Translational CNS Research - Cambridge\, MA
DESCRIPTION:MD Biosciences introduces novel models in neurophysiology and electrophysiology\, and translational pig models to advance CNS research.\n\n\n\n\n\n\nAbout this Event\n\n\nSymposium Overview \nSession I: Neurophysiology \n\n  Spinal cord injury in a dish\n  Synapse imaging: assessment of drug selection and efficacy\n  Histoneurology: IHC staining and analysis of neurological diseases\n  Patch Clamp method for drug screening\n\nSession II: Quantitative Output for Neurodegenerative Diseases Using in vivo Electrophysiology \n\nApplication of Electrophysiology as an endpoint in EAE Multiple Sclerosis studies\n\nSession III: Pig Models of Pain \n\nPost-operative pain\nModified post-operative pain\nNeuropathic pain\n\nMeet The Speakers \nSigal Meilin\, PhD\, Chief Scientific Officer \nDr. Meilin’s passion over 25 years has been in the understanding of neuro-degeneration and pain processes. Her research focus has been on exploring and creating true models of pain including translational models in pigs which closely mimic and forecast drug activity in humans. The MD Biosciences Innovalora laboratories\, under the scientific leadership of Sigal Meilin\, have become leaders in the discovery and validation of novel pathways and new candidate drugs. Sigal Meilin holds a PhD from Bar Ilan University in Tel Aviv\, Israel where she also continued her research involving multi-parametric monitoring of the living brain under oxygen stress and the cross talk between the immune system and the neuronal system in neurodegenerative disease. She was the leader of the pharmacology department of Pharmos\, Ltd\, prior to joining MD Biosciences in 2006. \nYoav Shulman\, PhD\, Neurophysiology Laboratory Manager \nDr. Shulman leads the neurophysiology and electrophysiology laboratories at MD Biosciences Innovalora. His primary focus is on method development and validation as well as execution of sponsor studies together with his team. Prior to joining MD Biosciences Innovalora\, Yoav completed his doctoral work at the Ben Gurion University of the Negev followed by a post-doctoral research at the Technion in Haifa\, Israel. Specialties include the establishment of spinal cord injury model using primary cultures from adult rat spine and peripheral nerve injury model using primary cultures from adult rat DRG. Other experiences include the establishment of an electrophysiology system for pharmacology assays using primary hippocampal cultures (Orenbuch et al. 2012)\, live Ca²ꜙ imaging and electrophysiology on ex-vivo brain slices (Sandler et al. 2016)\, live protein expression and movement\, identifying novel protein-protein interactions using a wide array of technologies (Shulman et al. 2015)\, Brain stem slices and electrophysiology measurements for ionic channel identification (Safori et al. 2015) and live EMPs\, SSEPs\, EEG and EMG for monitoring human brain and spine procedures in OR.
URL:https://scienceinboston.com/event/advances-in-preclinical-translational-cns-research-cambridge-ma/
LOCATION:Royal Sonesta Boston\, 40 Edwin H Land Boulevard\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191024T083000
DTEND;TZID=America/New_York:20191024T120000
DTSTAMP:20190909T151923Z
CREATED:20190909T151923Z
LAST-MODIFIED:20190909T151923Z
UID:27340-1571905800-1571918400@scienceinboston.com
SUMMARY:Advances in Preclinical & Translational CNS Research - Cambridge\, MA
DESCRIPTION:MD Biosciences introduces novel models in neurophysiology and electrophysiology\, and translational pig models to advance CNS research.\n\n\n\n\n\n\nAbout this Event\n\n\nSymposium Overview \nSession I: Neurophysiology \n\n  Spinal cord injury in a dish\n  Synapse imaging: assessment of drug selection and efficacy\n  Histoneurology: IHC staining and analysis of neurological diseases\n  Patch Clamp method for drug screening\n\nSession II: Quantitative Output for Neurodegenerative Diseases Using in vivo Electrophysiology \n\nApplication of Electrophysiology as an endpoint in EAE Multiple Sclerosis studies\n\nSession III: Pig Models of Pain \n\nPost-operative pain\nModified post-operative pain\nNeuropathic pain\n\nMeet The Speakers \nSigal Meilin\, PhD\, Chief Scientific Officer \nDr. Meilin’s passion over 25 years has been in the understanding of neuro-degeneration and pain processes. Her research focus has been on exploring and creating true models of pain including translational models in pigs which closely mimic and forecast drug activity in humans. The MD Biosciences Innovalora laboratories\, under the scientific leadership of Sigal Meilin\, have become leaders in the discovery and validation of novel pathways and new candidate drugs. Sigal Meilin holds a PhD from Bar Ilan University in Tel Aviv\, Israel where she also continued her research involving multi-parametric monitoring of the living brain under oxygen stress and the cross talk between the immune system and the neuronal system in neurodegenerative disease. She was the leader of the pharmacology department of Pharmos\, Ltd\, prior to joining MD Biosciences in 2006. \nYoav Shulman\, PhD\, Neurophysiology Laboratory Manager \nDr. Shulman leads the neurophysiology and electrophysiology laboratories at MD Biosciences Innovalora. His primary focus is on method development and validation as well as execution of sponsor studies together with his team. Prior to joining MD Biosciences Innovalora\, Yoav completed his doctoral work at the Ben Gurion University of the Negev followed by a post-doctoral research at the Technion in Haifa\, Israel. Specialties include the establishment of spinal cord injury model using primary cultures from adult rat spine and peripheral nerve injury model using primary cultures from adult rat DRG. Other experiences include the establishment of an electrophysiology system for pharmacology assays using primary hippocampal cultures (Orenbuch et al. 2012)\, live Ca²ꜙ imaging and electrophysiology on ex-vivo brain slices (Sandler et al. 2016)\, live protein expression and movement\, identifying novel protein-protein interactions using a wide array of technologies (Shulman et al. 2015)\, Brain stem slices and electrophysiology measurements for ionic channel identification (Safori et al. 2015) and live EMPs\, SSEPs\, EEG and EMG for monitoring human brain and spine procedures in OR.
URL:https://scienceinboston.com/event/advances-in-preclinical-translational-cns-research-cambridge-ma-2/
LOCATION:Royal Sonesta Boston\, 40 Edwin H Land Boulevard\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191024T080000
DTEND;TZID=America/New_York:20191026T170000
DTSTAMP:20191023T164731Z
CREATED:20191023T162950Z
LAST-MODIFIED:20191023T164731Z
UID:6943-1571904000-1572109200@scienceinboston.com
SUMMARY:2019 Joslin International Symposium: Bioenergetics and its Dysregulation in Diabetes
DESCRIPTION:Overview\n\nJOSLIN INTERNATIONAL SYMPOSIUM \nBioenergetics and its Dysregulation in Diabetes \nHeld jointly with Banting & Best Diabetes Center\, Toronto and University of Copenhagen \n  \nOctober 24th-October 26th\, 2019 \nJoseph B. Martin Conference Center\nHarvard Medical School\n77 Avenue Louis Pasteur\nBoston MA\, 02115 \n  \nOrganizing Co-Chairs: \nRohit Kulkarni\, M.D.\, Ph.D. \nKeith Blackwell\, M.D.\, Ph.D. \n  \nHighlights will include: \n\n25 World Renowned Speakers\nEmphasis on Beta Cells to honor the contributions of Dr. Gordon Weir and Dr. Susan Bonner-Weir\n\n  \nFor more information\, please email: \ninternational.symposium@joslin.harvard.edu \n  \nOnline Registration: \njoslininternationalsymposium.cvent.com
URL:https://scienceinboston.com/event/2019-joslin-international-symposium-bioenergetics-and-its-dysregulation-in-diabetes/
LOCATION:Joseph B. Martin Conference Center at the Harvard Medical School\, 77 Avenue Louis Pasteur\, Boston\, MA\, 02115\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191024T080000
DTEND;TZID=America/New_York:20191026T170000
DTSTAMP:20191023T162950Z
CREATED:20191023T162950Z
LAST-MODIFIED:20191023T162950Z
UID:27358-1571904000-1572109200@scienceinboston.com
SUMMARY:2019 Joslin International Symposium: Bioenergetics and its Dysregulation in Diabetes
DESCRIPTION:Overview\n\nJOSLIN INTERNATIONAL SYMPOSIUM \nBioenergetics and its Dysregulation in Diabetes \nHeld jointly with Banting & Best Diabetes Center\, Toronto and University of Copenhagen \n  \nOctober 24th-October 26th\, 2019 \nJoseph B. Martin Conference Center\nHarvard Medical School\n77 Avenue Louis Pasteur\nBoston MA\, 02115 \n  \nOrganizing Co-Chairs: \nRohit Kulkarni\, M.D.\, Ph.D. \nKeith Blackwell\, M.D.\, Ph.D. \n  \nHighlights will include: \n\n25 World Renowned Speakers\nEmphasis on Beta Cells to honor the contributions of Dr. Gordon Weir and Dr. Susan Bonner-Weir\n\n  \nFor more information\, please email: \ninternational.symposium@joslin.harvard.edu \n  \nOnline Registration: \njoslininternationalsymposium.cvent.com
URL:https://scienceinboston.com/event/2019-joslin-international-symposium-bioenergetics-and-its-dysregulation-in-diabetes-2/
LOCATION:Joseph B. Martin Conference Center at the Harvard Medical School\, 77 Avenue Louis Pasteur\, Boston\, MA\, 02115\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191024T080000
DTEND;TZID=America/New_York:20191025T170000
DTSTAMP:20191023T163302Z
CREATED:20191023T163302Z
LAST-MODIFIED:20191023T163302Z
UID:6946-1571904000-1572022800@scienceinboston.com
SUMMARY:Harnessing The Entire Immune System
DESCRIPTION:Overview\n\nJoin us for a unique 2-day symposium where leading scientists will come together to explore the power of the immune system and its role in the development of tomorrow’s therapies. Featuring thought-provoking presentations\, panel discussions and a networking reception\, each day’s dedicated agenda will cover the latest research\, new modalities\, and regulatory approaches that expedite development. Register for the full conference or your specific area of interest: \nDay 1: Cellular and Gene Therapies \nThe presentations throughout the day will focus on the complexities of cell and gene therapy development and will cover a range of topics including strategies to navigate through the current regulatory framework\, challenges in developing therapeutics for diseases requiring targeted administration to specific organ systems\, and genomic editing technologies for these product types. \nDay 2: Immuno-Oncology \nWill provide a forum where scientists will have the opportunity to review the current state of research for immuno-oncology and identify ways to develop therapies across various modalities\, including; antibodies therapies\, CAR-T cells\, viral vaccines\, oncolytic viruses and bicyclic peptides. We will consider novel strategies on the horizon\, and explore how the next generation of modalities may augment checkpoint inhibitors or act as stand-alone therapies\, and how they will change the landscape of oncology drug discovery.
URL:https://scienceinboston.com/event/harnessing-the-entire-immune-system/
LOCATION:Charles River Laboratories\, Cambridge\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191024T080000
DTEND;TZID=America/New_York:20191025T170000
DTSTAMP:20191023T163302Z
CREATED:20191023T163302Z
LAST-MODIFIED:20191023T163302Z
UID:27359-1571904000-1572022800@scienceinboston.com
SUMMARY:Harnessing The Entire Immune System
DESCRIPTION:Overview\n\nJoin us for a unique 2-day symposium where leading scientists will come together to explore the power of the immune system and its role in the development of tomorrow’s therapies. Featuring thought-provoking presentations\, panel discussions and a networking reception\, each day’s dedicated agenda will cover the latest research\, new modalities\, and regulatory approaches that expedite development. Register for the full conference or your specific area of interest: \nDay 1: Cellular and Gene Therapies \nThe presentations throughout the day will focus on the complexities of cell and gene therapy development and will cover a range of topics including strategies to navigate through the current regulatory framework\, challenges in developing therapeutics for diseases requiring targeted administration to specific organ systems\, and genomic editing technologies for these product types. \nDay 2: Immuno-Oncology \nWill provide a forum where scientists will have the opportunity to review the current state of research for immuno-oncology and identify ways to develop therapies across various modalities\, including; antibodies therapies\, CAR-T cells\, viral vaccines\, oncolytic viruses and bicyclic peptides. We will consider novel strategies on the horizon\, and explore how the next generation of modalities may augment checkpoint inhibitors or act as stand-alone therapies\, and how they will change the landscape of oncology drug discovery.
URL:https://scienceinboston.com/event/harnessing-the-entire-immune-system-2/
LOCATION:Charles River Laboratories\, Cambridge\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191023T173000
DTEND;TZID=America/New_York:20191023T200000
DTSTAMP:20191023T163400Z
CREATED:20191023T162712Z
LAST-MODIFIED:20191023T163400Z
UID:6940-1571851800-1571860800@scienceinboston.com
SUMMARY:WIB-Greater Boston: Betsy Myers on Leadership
DESCRIPTION:Nationally-known White House insider and leadership expert Betsy Myers will share insights\, strategies\, and best practices on authentic leadership and how to get results by understanding the people around you and their needs while being true to yourself. She’ll share examples of establishing meaningful relationships to drive your career forward. Betsy will address how as authentic leaders\, women can better engage men to boost gender equity in organizations. She will offer advice on how to develop trust-based professional relationships toward gender progress. \nProgram \n5:30 p.m. – 6:10 p.m. Registration\, Networking\, and Reception\n6:15 p.m. – 7:15 p.m. Presentation\n7:15 p.m  – 8:00 p.m. Networking \nSpeaker Bio \nBetsy Myers \nBetsy Myers chaired the Women for Obama organization and was the first director of the White House Office for Women’s Initiatives and Outreach under the Clinton administration. She has also been executive director of Harvard’s Center for Public Leadership and founding director of the Center for Women in Business at Bentley University. Betsy published Take the Lead: Motivate\, Inspire\, and Bring Out the Best in Yourself and Everyone Around You and is currently working on a second book on leadership. \nPricing Information \nUntil October 18\, 2019 \n\nMembers: $30\nNon-Members/Free Unlimited Guest Members*: $60\n\nBeginning October 19\, 2019 \n\nMembers: $35\nNon-Members/Free Unlimited Guest Members*: $65\n\n*To access the Member rate\, click here to purchase a WIB membership. \nWalk-Ins Accepted? \nYes* \n* – Walk-ins will be accepted until event capacity is reached. \nMaximum Capacity  \n100 \n  \nParking Information \nMetered parking and garages in the area. \nDirections from Public Transit \nT Stop: Silver Line\, Courthouse
URL:https://scienceinboston.com/event/wib-greater-boston-betsy-myers-on-leadership/
LOCATION:Fish & Richardson P.C.\, One Marina Park Drive\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191023T173000
DTEND;TZID=America/New_York:20191023T200000
DTSTAMP:20191023T162712Z
CREATED:20191023T162712Z
LAST-MODIFIED:20191023T162712Z
UID:27357-1571851800-1571860800@scienceinboston.com
SUMMARY:WIB-Greater Boston: Betsy Myers on Leadership
DESCRIPTION:Nationally-known White House insider and leadership expert Betsy Myers will share insights\, strategies\, and best practices on authentic leadership and how to get results by understanding the people around you and their needs while being true to yourself. She’ll share examples of establishing meaningful relationships to drive your career forward. Betsy will address how as authentic leaders\, women can better engage men to boost gender equity in organizations. She will offer advice on how to develop trust-based professional relationships toward gender progress. \nProgram \n5:30 p.m. – 6:10 p.m. Registration\, Networking\, and Reception\n6:15 p.m. – 7:15 p.m. Presentation\n7:15 p.m  – 8:00 p.m. Networking \nSpeaker Bio \nBetsy Myers \nBetsy Myers chaired the Women for Obama organization and was the first director of the White House Office for Women’s Initiatives and Outreach under the Clinton administration. She has also been executive director of Harvard’s Center for Public Leadership and founding director of the Center for Women in Business at Bentley University. Betsy published Take the Lead: Motivate\, Inspire\, and Bring Out the Best in Yourself and Everyone Around You and is currently working on a second book on leadership. \nPricing Information \nUntil October 18\, 2019 \n\nMembers: $30\nNon-Members/Free Unlimited Guest Members*: $60\n\nBeginning October 19\, 2019 \n\nMembers: $35\nNon-Members/Free Unlimited Guest Members*: $65\n\n*To access the Member rate\, click here to purchase a WIB membership. \nWalk-Ins Accepted? \nYes* \n* – Walk-ins will be accepted until event capacity is reached. \nMaximum Capacity  \n100 \n  \nParking Information \nMetered parking and garages in the area. \nDirections from Public Transit \nT Stop: Silver Line\, Courthouse
URL:https://scienceinboston.com/event/wib-greater-boston-betsy-myers-on-leadership-2/
LOCATION:Fish & Richardson P.C.\, One Marina Park Drive\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191022T083000
DTEND;TZID=America/New_York:20191022T163000
DTSTAMP:20190909T150711Z
CREATED:20190909T150711Z
LAST-MODIFIED:20190909T150711Z
UID:6446-1571733000-1571761800@scienceinboston.com
SUMMARY:PerkinElmer Nexus East Coast User Meeting 2019
DESCRIPTION:Please Join PerkinElmer for an interactive day of learning at our 2019 Nexus East Coast User Meeting at Merck Research Laboratories Boston location. \nKey notes: \n\nDavid Wang VP/General Manager PerkinElmer Informatics\nMichael O’Connell  Chief Data Officer TIBCO\nTo be confirmed Merck\n\nCase study presentations by your peers on ELN & Spotfire solutions \nSpotlight presentations on PerkinElmer solutions \nNetworking
URL:https://scienceinboston.com/event/perkinelmer-nexus-east-coast-user-meeting-2019/
LOCATION:Merck Research Laboratories\, 33 Avenue Louis Pasteur\, Boston\, MA\, 02115\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191022T083000
DTEND;TZID=America/New_York:20191022T163000
DTSTAMP:20190909T150711Z
CREATED:20190909T150711Z
LAST-MODIFIED:20190909T150711Z
UID:27336-1571733000-1571761800@scienceinboston.com
SUMMARY:PerkinElmer Nexus East Coast User Meeting 2019
DESCRIPTION:Please Join PerkinElmer for an interactive day of learning at our 2019 Nexus East Coast User Meeting at Merck Research Laboratories Boston location. \nKey notes: \n\nDavid Wang VP/General Manager PerkinElmer Informatics\nMichael O’Connell  Chief Data Officer TIBCO\nTo be confirmed Merck\n\nCase study presentations by your peers on ELN & Spotfire solutions \nSpotlight presentations on PerkinElmer solutions \nNetworking
URL:https://scienceinboston.com/event/perkinelmer-nexus-east-coast-user-meeting-2019-2/
LOCATION:Merck Research Laboratories\, 33 Avenue Louis Pasteur\, Boston\, MA\, 02115\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191018T183000
DTEND;TZID=America/New_York:20191018T200000
DTSTAMP:20190909T151629Z
CREATED:20190909T151629Z
LAST-MODIFIED:20190909T151629Z
UID:6454-1571423400-1571428800@scienceinboston.com
SUMMARY:ETH Meets Boston 2019
DESCRIPTION:Description\nRETHINK Drug Discovery\nRecent advances in chemical synthesis\, biological testing\, and artificial intelligence (AI) allow for greater automation in the drug discovery process. AI systems that generate novel design suppositions\, as well as\, cope with multiple design objectives provide a basis for further automation in some aspects of drug discovery. Automation could potentially accelerate timeframes for compound design and optimization. It could also enable better decision making in early-stage pharmaceutical discovery that translates into late-stage clinical validation. However\, such approaches also raise considerable conceptual\, technical\, and organizational challenges. \nThis symposium aims to address the latest advances of this rapidly progressing field of science\, by bringing together leading researchers to present the state-of-the-art in drug discovery. Together they will make daring predictions surrounding the possibilities and limitations of drug discovery using machine intelligence. \nProgramme and further information
URL:https://scienceinboston.com/event/eth-meets-boston-2019/
LOCATION:District Hall Boston\, 75 Northern Avenue\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191018T183000
DTEND;TZID=America/New_York:20191018T200000
DTSTAMP:20190909T151629Z
CREATED:20190909T151629Z
LAST-MODIFIED:20190909T151629Z
UID:27339-1571423400-1571428800@scienceinboston.com
SUMMARY:ETH Meets Boston 2019
DESCRIPTION:Description\nRETHINK Drug Discovery\nRecent advances in chemical synthesis\, biological testing\, and artificial intelligence (AI) allow for greater automation in the drug discovery process. AI systems that generate novel design suppositions\, as well as\, cope with multiple design objectives provide a basis for further automation in some aspects of drug discovery. Automation could potentially accelerate timeframes for compound design and optimization. It could also enable better decision making in early-stage pharmaceutical discovery that translates into late-stage clinical validation. However\, such approaches also raise considerable conceptual\, technical\, and organizational challenges. \nThis symposium aims to address the latest advances of this rapidly progressing field of science\, by bringing together leading researchers to present the state-of-the-art in drug discovery. Together they will make daring predictions surrounding the possibilities and limitations of drug discovery using machine intelligence. \nProgramme and further information
URL:https://scienceinboston.com/event/eth-meets-boston-2019-2/
LOCATION:District Hall Boston\, 75 Northern Avenue\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20191016T090000
DTEND;TZID=America/Vancouver:20191016T170000
DTSTAMP:20191008T135307Z
CREATED:20190909T152133Z
LAST-MODIFIED:20191008T135307Z
UID:6460-1571216400-1571245200@scienceinboston.com
SUMMARY:Neural Mechanisms of Memory and Cognition
DESCRIPTION:Picower Institute for Learning and Memory \n  \nFall 2019 Symposium \n  \nNeural Mechanisms of Memory and Cognition \n  \nWednesday\, October 16\, 2019 | 9:00am – 5:00pm \n  \nMIT Building 46\, Singleton Auditorium (46-3002) \n  \nThe Picower Institute is a community of scientists dedicated to understanding the mechanisms that drive learning and memory and related functions such as cognition\, emotion\, perception and consciousness. We explore the brain at multiple scales\, from genes and molecules\, to cells and synapses\, to circuits and systems\, producing novel insights into how disruptions in these mechanisms can lead to developmental\, psychiatric or neurodegenerative disease. \n  \nIn keeping with that mission\, the theme of the symposium is “Neural Mechanisms of Memory and Cognition.” \n  \nSpeakers: \n  \nJessica Cardin\, PhD\, Yale University \n  \nDiane Chan\, MD\, PhD\, Picower Institute at MIT \n  \nMartin Fuhrmann\, PhD\, German Center for Neurodegenerative Diseases \n  \nLisa Giocomo\, PhD\, Stanford University \n  \nMichael Halassa\, PhD\, MIT \n  \nChristopher Harvey\, Harvard University \n  \nThomas McHugh\, PhD\, RIKEN Center for Brain Science \n  \nElly Nedivi\, PhD\, Picower Institute at MIT \n  \nAlvaro Pascual-Leone\, MD\, PhD\, Beth Israel Deaconess Medical Center\, Harvard Medical School \n  \nMu-ming Poo\, PhD\, Institute of Neuroscience\, Shanghai \n  \nAndreas Schaefer\, PhD\, Francis Crick Institute \n  \nFAQs \n  \nWhat are my transportation/parking options for getting to and from the event? \n  \nParking cannot be provided for this event. We are easily acessible via the MBTA Red Line – Kendall/MIT stop as well as numerous bus lines including the 1\, CT1\, 64\, 68\, and 85. \n  \nDo I have to bring my printed ticket to the event? \n  \nNo\, you do not need to bring a printed ticket. \n  \nCan I update my registration information? \n  \nYes. \n  \nIs it ok if the name on my ticket or registration doesn’t match the person who attends?
URL:https://scienceinboston.com/event/neural-mechanisms-of-memory-and-cognition/
LOCATION:The Picower Institute for Learning and Memory\, 43 Vassar Street\, 3rd Floor\, Singleton Auditorium\, 46-3002\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20191016T090000
DTEND;TZID=America/Vancouver:20191016T170000
DTSTAMP:20190909T152133Z
CREATED:20190909T152133Z
LAST-MODIFIED:20190909T152133Z
UID:27341-1571216400-1571245200@scienceinboston.com
SUMMARY:Neural Mechanisms of Memory and Cognition
DESCRIPTION:Picower Institute for Learning and Memory \n  \nFall 2019 Symposium \n  \nNeural Mechanisms of Memory and Cognition \n  \nWednesday\, October 16\, 2019 | 9:00am – 5:00pm \n  \nMIT Building 46\, Singleton Auditorium (46-3002) \n  \nThe Picower Institute is a community of scientists dedicated to understanding the mechanisms that drive learning and memory and related functions such as cognition\, emotion\, perception and consciousness. We explore the brain at multiple scales\, from genes and molecules\, to cells and synapses\, to circuits and systems\, producing novel insights into how disruptions in these mechanisms can lead to developmental\, psychiatric or neurodegenerative disease. \n  \nIn keeping with that mission\, the theme of the symposium is “Neural Mechanisms of Memory and Cognition.” \n  \nSpeakers: \n  \nJessica Cardin\, PhD\, Yale University \n  \nDiane Chan\, MD\, PhD\, Picower Institute at MIT \n  \nMartin Fuhrmann\, PhD\, German Center for Neurodegenerative Diseases \n  \nLisa Giocomo\, PhD\, Stanford University \n  \nMichael Halassa\, PhD\, MIT \n  \nChristopher Harvey\, Harvard University \n  \nThomas McHugh\, PhD\, RIKEN Center for Brain Science \n  \nElly Nedivi\, PhD\, Picower Institute at MIT \n  \nAlvaro Pascual-Leone\, MD\, PhD\, Beth Israel Deaconess Medical Center\, Harvard Medical School \n  \nMu-ming Poo\, PhD\, Institute of Neuroscience\, Shanghai \n  \nAndreas Schaefer\, PhD\, Francis Crick Institute \n  \nFAQs \n  \nWhat are my transportation/parking options for getting to and from the event? \n  \nParking cannot be provided for this event. We are easily acessible via the MBTA Red Line – Kendall/MIT stop as well as numerous bus lines including the 1\, CT1\, 64\, 68\, and 85. \n  \nDo I have to bring my printed ticket to the event? \n  \nNo\, you do not need to bring a printed ticket. \n  \nCan I update my registration information? \n  \nYes. \n  \nIs it ok if the name on my ticket or registration doesn’t match the person who attends?
URL:https://scienceinboston.com/event/neural-mechanisms-of-memory-and-cognition-2/
LOCATION:The Picower Institute for Learning and Memory\, 43 Vassar Street\, 3rd Floor\, Singleton Auditorium\, 46-3002\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191014T083000
DTEND;TZID=America/New_York:20191014T163000
DTSTAMP:20190909T151047Z
CREATED:20190909T151047Z
LAST-MODIFIED:20190909T151047Z
UID:6448-1571041800-1571070600@scienceinboston.com
SUMMARY:Navigating through Maze of In-vitro Diagnostics (IVD) Regulations: A systematic approach from Regulatory Strategy to Regulatory Approvals in U.S./Europe/Canada
DESCRIPTION:Course Description:\nIn-vitro Diagnostics (IVD) products provide critical information on patient’s health condition\, based on which the healthcare provider develops and administers treatment plan. Although IVDs are medical devices\, they are regulated under a separate set of regulations in U.S.\, Europe\, and Canada. \nThis 2 day interactive course on in-vitro diagnostics is structured to understand the different set of IVD regulations\, how to navigate through this maze of IVD regulations\, and to win regulatory approvals. This In-vitro Diagnostics (IVD ) course will make the attendees understand the IVD regulations and develop regulatory strategies that secure regulatory approvals. \n Learning Objectives: \nAfter completion of this two day interactive course on IVD\, the attendee will be able to: \n\nUnderstand why IVD is regulated differently.\nAn overview of IVD Regulations – U.S. FDA.\, Europe (MDD)\, Canada.\nDevelop Regulatory Strategies and determine Regulatory Pathways.\nInclusion and exclusion of data and information for different submission.\nFormat and Content of premarket submissions.\nProduct Label and Labeling for IVDs.\nWorking and interacting with the reviewers and regulators.\nTips and Suggestions to secure rapid regulatory approvals.\n\n\nWho will benefit:\nThis interactive course is specifically developed for individuals\, who are responsible for the design\, development\, manufacturing\, marketing\, and distribution of IVD products. This course is highly recommended for personnel involved in any of the following functions: \n\nDepartment Managers (middle management)\nResearch & Development (R&D)\nProduct Design & Development\nValidation Engineering\nRegulatory Affairs\nQuality Assurance\nQuality Control\nManufacturing/Production\n\nSpeaker: \nRobert Di Tullio\nPresident\, Di Tullio Consulting Inc \nRobert Di Tullio is an experienced leader in the diagnostics industry. For 45 years\, he has held various positions with multiple organizations\, with a particular emphasis on regulatory\, quality and clinical affairs management. \nRobert has provided companies\, large\, small and start-up\, with the vision\, strategy and leadership to promote commercial success while assuring compliance with global regulations and initiatives in the competitive marketplace. \nAs a solutions oriented leader\, Robert has consistently achieved positive results in all industry aspects for regulatory and operational processes and systems. \nFor Registration – https://www.complianceonline.com/in-vitro-diagnostics-ivd-regulatory-approvals-in-us-europe-canada-seminar-training-80148SEM-prdsm?channel=eventbrite \n\nNote: Use coupon code < REFERRAL10 > and get 10% off on registration.
URL:https://scienceinboston.com/event/navigating-through-maze-of-in-vitro-diagnostics-ivd-regulations-a-systematic-approach-from-regulatory-strategy-to-regulatory-approvals-in-u-s-europe-canada/
LOCATION:ComplianceOnline\, Boston\, MA\, 02111\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191014T083000
DTEND;TZID=America/New_York:20191014T163000
DTSTAMP:20190909T151047Z
CREATED:20190909T151047Z
LAST-MODIFIED:20190909T151047Z
UID:27337-1571041800-1571070600@scienceinboston.com
SUMMARY:Navigating through Maze of In-vitro Diagnostics (IVD) Regulations: A systematic approach from Regulatory Strategy to Regulatory Approvals in U.S./Europe/Canada
DESCRIPTION:Course Description:\nIn-vitro Diagnostics (IVD) products provide critical information on patient’s health condition\, based on which the healthcare provider develops and administers treatment plan. Although IVDs are medical devices\, they are regulated under a separate set of regulations in U.S.\, Europe\, and Canada. \nThis 2 day interactive course on in-vitro diagnostics is structured to understand the different set of IVD regulations\, how to navigate through this maze of IVD regulations\, and to win regulatory approvals. This In-vitro Diagnostics (IVD ) course will make the attendees understand the IVD regulations and develop regulatory strategies that secure regulatory approvals. \n Learning Objectives: \nAfter completion of this two day interactive course on IVD\, the attendee will be able to: \n\nUnderstand why IVD is regulated differently.\nAn overview of IVD Regulations – U.S. FDA.\, Europe (MDD)\, Canada.\nDevelop Regulatory Strategies and determine Regulatory Pathways.\nInclusion and exclusion of data and information for different submission.\nFormat and Content of premarket submissions.\nProduct Label and Labeling for IVDs.\nWorking and interacting with the reviewers and regulators.\nTips and Suggestions to secure rapid regulatory approvals.\n\n\nWho will benefit:\nThis interactive course is specifically developed for individuals\, who are responsible for the design\, development\, manufacturing\, marketing\, and distribution of IVD products. This course is highly recommended for personnel involved in any of the following functions: \n\nDepartment Managers (middle management)\nResearch & Development (R&D)\nProduct Design & Development\nValidation Engineering\nRegulatory Affairs\nQuality Assurance\nQuality Control\nManufacturing/Production\n\nSpeaker: \nRobert Di Tullio\nPresident\, Di Tullio Consulting Inc \nRobert Di Tullio is an experienced leader in the diagnostics industry. For 45 years\, he has held various positions with multiple organizations\, with a particular emphasis on regulatory\, quality and clinical affairs management. \nRobert has provided companies\, large\, small and start-up\, with the vision\, strategy and leadership to promote commercial success while assuring compliance with global regulations and initiatives in the competitive marketplace. \nAs a solutions oriented leader\, Robert has consistently achieved positive results in all industry aspects for regulatory and operational processes and systems. \nFor Registration – https://www.complianceonline.com/in-vitro-diagnostics-ivd-regulatory-approvals-in-us-europe-canada-seminar-training-80148SEM-prdsm?channel=eventbrite \n\nNote: Use coupon code < REFERRAL10 > and get 10% off on registration.
URL:https://scienceinboston.com/event/navigating-through-maze-of-in-vitro-diagnostics-ivd-regulations-a-systematic-approach-from-regulatory-strategy-to-regulatory-approvals-in-u-s-europe-canada-2/
LOCATION:ComplianceOnline\, Boston\, MA\, 02111\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191010T173000
DTEND;TZID=America/New_York:20191010T193000
DTSTAMP:20190909T151301Z
CREATED:20190909T151301Z
LAST-MODIFIED:20190909T151301Z
UID:6451-1570728600-1570735800@scienceinboston.com
SUMMARY:Whitehead Connects with John Maraganore\, PhD
DESCRIPTION:Description\nJoin us on Thursday\, October 10 for Bringing RNAi From Basic Science to Patients presented by Dr. John Maraganore who has served as CEO and Director of Alnylam since 2002. \nPrior to Alnylam\, Dr. Maraganore served as an officer and a member of the management team for Millennium Pharmaceuticals\, Inc. \nAs Senior Vice President: Strategic Product Development for Millennium\, he was responsible for the company’s product franchises in oncology\, and cardiovascular\, inflammatory\, and metabolic diseases. He was previously Vice President: Strategic Planning and M&A and\, prior to that\, he was General Manager of Millennium BioTherapeutics\, Inc.\, a former subsidiary of Millennium. \nBefore Millennium he served as Director of Molecular Biology and Director of Market and Business Development at Biogen\, Inc. At Biogen\, Dr. Maraganore invented and led the discovery and development of ANGIOMAX® (bivalirudin) for injection\, formerly HIRULOGTM and currently marketed by The Medicines Company. Prior to Biogen\, Dr. Maraganore was a scientist at ZymoGenetics\, Inc.\, and the Upjohn Company. \nDr. Maraganore received his MS and PhD in biochemistry and molecular biology at the University of Chicago. He is a Director for Agios Pharmaceuticals. Dr. Maraganore is the former Chair of the Biotechnology Industry Organization (BIO) Board\, and is a member of the BIO Executive Committee.
URL:https://scienceinboston.com/event/whitehead-connects-with-john-maraganore-phd/
LOCATION:Whitehead Institute for Biomedical Research\, 455 Main Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191010T173000
DTEND;TZID=America/New_York:20191010T193000
DTSTAMP:20190909T151301Z
CREATED:20190909T151301Z
LAST-MODIFIED:20190909T151301Z
UID:27338-1570728600-1570735800@scienceinboston.com
SUMMARY:Whitehead Connects with John Maraganore\, PhD
DESCRIPTION:Description\nJoin us on Thursday\, October 10 for Bringing RNAi From Basic Science to Patients presented by Dr. John Maraganore who has served as CEO and Director of Alnylam since 2002. \nPrior to Alnylam\, Dr. Maraganore served as an officer and a member of the management team for Millennium Pharmaceuticals\, Inc. \nAs Senior Vice President: Strategic Product Development for Millennium\, he was responsible for the company’s product franchises in oncology\, and cardiovascular\, inflammatory\, and metabolic diseases. He was previously Vice President: Strategic Planning and M&A and\, prior to that\, he was General Manager of Millennium BioTherapeutics\, Inc.\, a former subsidiary of Millennium. \nBefore Millennium he served as Director of Molecular Biology and Director of Market and Business Development at Biogen\, Inc. At Biogen\, Dr. Maraganore invented and led the discovery and development of ANGIOMAX® (bivalirudin) for injection\, formerly HIRULOGTM and currently marketed by The Medicines Company. Prior to Biogen\, Dr. Maraganore was a scientist at ZymoGenetics\, Inc.\, and the Upjohn Company. \nDr. Maraganore received his MS and PhD in biochemistry and molecular biology at the University of Chicago. He is a Director for Agios Pharmaceuticals. Dr. Maraganore is the former Chair of the Biotechnology Industry Organization (BIO) Board\, and is a member of the BIO Executive Committee.
URL:https://scienceinboston.com/event/whitehead-connects-with-john-maraganore-phd-2/
LOCATION:Whitehead Institute for Biomedical Research\, 455 Main Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191009T173000
DTEND;TZID=America/New_York:20191009T183000
DTSTAMP:20191008T135433Z
CREATED:20190909T150131Z
LAST-MODIFIED:20191008T135433Z
UID:6440-1570642200-1570645800@scienceinboston.com
SUMMARY:Teaching Old Bacteria New Tricks
DESCRIPTION:Overview: \n  \nKristala L. J. Prather\, Arthur D. Little Professor of Chemical Engineering\, MacVicar Faculty Fellow at MIT\, will present the sixteenth lecture in the series\, “Thinking Out Loud: Deciphering Mysteries of our World and Beyond.” \n  \nAbout the Lecture: \n  \nBiology is an exquisite chemist\, each cell comprised of numerous chemical structures. Microbes can be engineered to reroute and extend biosynthetic pathways to make molecules for human use\, ranging from drugs to materials. Yet\, biology is also designed for reproduction\, each cell aiming to make more of itself. Come learn how Kris balances these competing objectives to teach old bacteria some new tricks. \n  \nAbout the Series: \n  \nScientists and engineers are often perceived as living intellectual lives that are mysterious — simultaneously wondrous and arcane. The Brown University Presidential Colloquium Series\, Thinking Out Loud: Deciphering Mysteries of Our World and Beyond\, showcases profoundly creative and accomplished scholars who not only tackle some of the biggest “Big Questions” there are\, but also skillfully communicate their inner visions to broad audiences. Like last year\, this year’s Thinking Out Loud Presidential Colloquium Speakers consider a wide range of urgent\, pervasive questions. Why is speech so rare and what’s it got to do with genes? If you can compute it to see it\, can you be it? Is arthritis really a life sentence? Can understanding then tiniest splicers lead to better health? Please join us to hear these very special minds Think Out Loud. \n  \nRegistration Information: \n  \nThis event is free and open to the public. The auditorium will open at 5:00 PM for seating. Guests are asked to arrive to the auditorium no later than 5:20 PM. At 5:20 PM pre-registered guests are no longer guaranteed seating and all available seats will be open to general admission. If you have questions about the event\, or to request special services\, accomodations\, or assistance for this event\, please University Event and Conference Services at universityevents@brown.edu as far in advance of the event as possible.
URL:https://scienceinboston.com/event/teaching-old-bacteria-new-tricks/
LOCATION:Brown University\, Salomon Hall\, Room 001\, 79 Waterman St\, Providence\, RI\, 02912\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191009T173000
DTEND;TZID=America/New_York:20191009T183000
DTSTAMP:20190909T150131Z
CREATED:20190909T150131Z
LAST-MODIFIED:20190909T150131Z
UID:27334-1570642200-1570645800@scienceinboston.com
SUMMARY:Teaching Old Bacteria New Tricks
DESCRIPTION:Overview: \n  \nKristala L. J. Prather\, Arthur D. Little Professor of Chemical Engineering\, MacVicar Faculty Fellow at MIT\, will present the sixteenth lecture in the series\, “Thinking Out Loud: Deciphering Mysteries of our World and Beyond.” \n  \nAbout the Lecture: \n  \nBiology is an exquisite chemist\, each cell comprised of numerous chemical structures. Microbes can be engineered to reroute and extend biosynthetic pathways to make molecules for human use\, ranging from drugs to materials. Yet\, biology is also designed for reproduction\, each cell aiming to make more of itself. Come learn how Kris balances these competing objectives to teach old bacteria some new tricks. \n  \nAbout the Series: \n  \nScientists and engineers are often perceived as living intellectual lives that are mysterious — simultaneously wondrous and arcane. The Brown University Presidential Colloquium Series\, Thinking Out Loud: Deciphering Mysteries of Our World and Beyond\, showcases profoundly creative and accomplished scholars who not only tackle some of the biggest “Big Questions” there are\, but also skillfully communicate their inner visions to broad audiences. Like last year\, this year’s Thinking Out Loud Presidential Colloquium Speakers consider a wide range of urgent\, pervasive questions. Why is speech so rare and what’s it got to do with genes? If you can compute it to see it\, can you be it? Is arthritis really a life sentence? Can understanding then tiniest splicers lead to better health? Please join us to hear these very special minds Think Out Loud. \n  \nRegistration Information: \n  \nThis event is free and open to the public. The auditorium will open at 5:00 PM for seating. Guests are asked to arrive to the auditorium no later than 5:20 PM. At 5:20 PM pre-registered guests are no longer guaranteed seating and all available seats will be open to general admission. If you have questions about the event\, or to request special services\, accomodations\, or assistance for this event\, please University Event and Conference Services at universityevents@brown.edu as far in advance of the event as possible.
URL:https://scienceinboston.com/event/teaching-old-bacteria-new-tricks-2/
LOCATION:Brown University\, Salomon Hall\, Room 001\, 79 Waterman St\, Providence\, RI\, 02912\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191008T083000
DTEND;TZID=America/New_York:20191008T150000
DTSTAMP:20190909T150423Z
CREATED:20190909T150423Z
LAST-MODIFIED:20190909T150423Z
UID:6443-1570523400-1570546800@scienceinboston.com
SUMMARY:Material Characterization with Pyrolysis GC/MS
DESCRIPTION:We’re excited to host a seminar at Jordi Labs in Mansfield\, MA on extending the limits of material characterization with pyrolysis-GC/MS.\n\n\n\n\n\n\nAbout this Event\n\n\nIt’s time to demystify pyrolysis. Whether you are identifying materials for trouble-shooting\, raw material screening\, competitive analysis\, research\, and development\, or quality control\, discover the power and versatility of modern multi-mode pyrolyzers. When paired with an Agilent GC/MS\, the Frontier pyrolysis system can take your material characterization to new levels! \nQuantum Analytics and Frontier Laboratories are excited to host a seminar at Jordi Labs on extending the limits of material characterization with pyrolysis-GC/MS. This technique is applied to just about every industry imaginable: polymers\, additives\, inks\, paints and coatings\, paper\, adhesives\, elastomers\, shale rocks\, and even biomass. Imagine being able to characterize virtually any organic material with little to no sample preparation. With the Frontier pyrolysis instrument\, you extend the limits of material characterization in your lab.
URL:https://scienceinboston.com/event/material-characterization-with-pyrolysis-gc-ms/
LOCATION:Jordi Labs\, 200 Gilbert Street\, Mansfield\, MA\, 02048\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191008T083000
DTEND;TZID=America/New_York:20191008T150000
DTSTAMP:20190909T150423Z
CREATED:20190909T150423Z
LAST-MODIFIED:20190909T150423Z
UID:27335-1570523400-1570546800@scienceinboston.com
SUMMARY:Material Characterization with Pyrolysis GC/MS
DESCRIPTION:We’re excited to host a seminar at Jordi Labs in Mansfield\, MA on extending the limits of material characterization with pyrolysis-GC/MS.\n\n\n\n\n\n\nAbout this Event\n\n\nIt’s time to demystify pyrolysis. Whether you are identifying materials for trouble-shooting\, raw material screening\, competitive analysis\, research\, and development\, or quality control\, discover the power and versatility of modern multi-mode pyrolyzers. When paired with an Agilent GC/MS\, the Frontier pyrolysis system can take your material characterization to new levels! \nQuantum Analytics and Frontier Laboratories are excited to host a seminar at Jordi Labs on extending the limits of material characterization with pyrolysis-GC/MS. This technique is applied to just about every industry imaginable: polymers\, additives\, inks\, paints and coatings\, paper\, adhesives\, elastomers\, shale rocks\, and even biomass. Imagine being able to characterize virtually any organic material with little to no sample preparation. With the Frontier pyrolysis instrument\, you extend the limits of material characterization in your lab.
URL:https://scienceinboston.com/event/material-characterization-with-pyrolysis-gc-ms-2/
LOCATION:Jordi Labs\, 200 Gilbert Street\, Mansfield\, MA\, 02048\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20191007T140000
DTEND;TZID=America/Vancouver:20191007T190000
DTSTAMP:20190717T200736Z
CREATED:20190717T200524Z
LAST-MODIFIED:20190717T200736Z
UID:5917-1570456800-1570474800@scienceinboston.com
SUMMARY:LRIG New England 2019 Fall Seminars and Exhibitions
DESCRIPTION:We are happy to invite you to our annual LRIG New England 2019 Fall Seminars and Exhibition which is being held at the Boston Marriott Cambridge Hotel. This is a free event to our members where you can visit our seminars and exhibition floor and talk to our participating speakers and exhibitors. There are also free workshops provided by some of exhibitors where current issues and topics are discussed. There are 70 exhibitor spots available. \nFood and non-alcoholic beverages are provided for free to all members and exhibitors during this event. For those interested in purchasing alcoholic beverages a bartender is available to provide you this service for a fee. \nThere are multiple parking options available including two parking garages within a block and street parking is available where appropriate. We do not validate parking for this event. \nThe Grand Ballroom is located on the 2nd floor of the hotel. It can be accessed using the escalator or the elevator. The Discovery and Endeavor meeting rooms are located on the 3rd floor. There is a stairwell just outside the Grand Ballroom which will lead directly to the meeting rooms. The elevator will also access the 3rd floor meeting rooms from the 2nd floor. \nAgenda: \n\nExhibition Hall: 2-7pm\nWorkshops: 4-6pm
URL:https://scienceinboston.com/event/lrig-new-england-2019-fall-seminars-and-exhibitions/
LOCATION:Boston Marriott Cambridge\, 50 Broadway\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20191007T140000
DTEND;TZID=America/Vancouver:20191007T190000
DTSTAMP:20190717T200524Z
CREATED:20190717T200524Z
LAST-MODIFIED:20190717T200524Z
UID:27289-1570456800-1570474800@scienceinboston.com
SUMMARY:LRIG New England 2019 Fall Seminars and Exhibitions
DESCRIPTION:We are happy to invite you to our annual LRIG New England 2019 Fall Seminars and Exhibition which is being held at the Boston Marriott Cambridge Hotel. This is a free event to our members where you can visit our seminars and exhibition floor and talk to our participating speakers and exhibitors. There are also free workshops provided by some of exhibitors where current issues and topics are discussed. There are 70 exhibitor spots available. \nFood and non-alcoholic beverages are provided for free to all members and exhibitors during this event. For those interested in purchasing alcoholic beverages a bartender is available to provide you this service for a fee. \nThere are multiple parking options available including two parking garages within a block and street parking is available where appropriate. We do not validate parking for this event. \nThe Grand Ballroom is located on the 2nd floor of the hotel. It can be accessed using the escalator or the elevator. The Discovery and Endeavor meeting rooms are located on the 3rd floor. There is a stairwell just outside the Grand Ballroom which will lead directly to the meeting rooms. The elevator will also access the 3rd floor meeting rooms from the 2nd floor. \nAgenda: \n\nExhibition Hall: 2-7pm\nWorkshops: 4-6pm
URL:https://scienceinboston.com/event/lrig-new-england-2019-fall-seminars-and-exhibitions-2/
LOCATION:Boston Marriott Cambridge\, 50 Broadway\, Cambridge\, MA\, 02142\, United States
END:VEVENT
END:VCALENDAR